ArticleCancer immunology, immunotherapy : CII2024

Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer.

Cecilia Olsson Ladjevardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.